Alyssum Therapeutics

Cambridge, MA · Founded 2011 · Privately Held (backing)

Developer of supramolecular therapeutics designed for cancer patients. Alyssum Therapeutics is based in Cambridge, MA and was founded in 2011. Its last reported valuation was $13.3 million in Mar 2017. It has raised $32.7 million.

Last reported valuation

$13.3M

Oct 2026

Priced at

—

Total raised

$32.7M

Last round

—

How much has Alyssum Therapeutics raised?

$32.7Macross 0 recorded rounds

Free account

More of Alyssum Therapeutics with a free account

·Watch Alyssum Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Alyssum Therapeutics investors

10 investors are on record for Alyssum Therapeutics, including Accel, REMUS Capital, FemHealth Ventures and Romulus Capital.

For fundraisers

Raising for a company like Alyssum Therapeutics?

10 investors have backed Alyssum Therapeutics.

See all 10 investors →

Frequently asked about Alyssum Therapeutics

How much has Alyssum Therapeutics raised?: Alyssum Therapeutics has raised $32.7M in total across 0 recorded funding rounds.